Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vigil Neuroscience, Inc. (VIGL) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vigil Neuroscience, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1827087.
Total stock buying since 2022: $70,818,121.
Total stock sales since 2022: $4,200.
Total stock option exercises since 2022: $567.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 27,000 | $48,970 | 0 | $0 | 0 | $0 |
| 2023 | 4,000 | $15,000 | 0 | $0 | 0 | $0 |
| 2022 | 5,098,195 | $70,754,151 | 300 | $4,200 | 300 | $567 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-12 | 27,000 | $48,970 | 0 | $0 | 0 | $0 |
| 2023-11 | 4,000 | $15,000 | 0 | $0 | 0 | $0 |
| 2022-11 | 0 | $0 | 300 | $4,200 | 300 | $567 |
| 2022-05 | 55,195 | $172,548 | 0 | $0 | 0 | $0 |
| 2022-03 | 3,000 | $21,603 | 0 | $0 | 0 | $0 |
| 2022-01 | 5,040,000 | $70,560,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-19 | Budd Haeberlein Samantha L. | Buy | 12,000 | 1.71 | 20,520 |
| 2024-12-19 | Magovcevic-liebisch Ivana (President and CEO) | Buy | 5,000 | 1.68 | 8,400 |
| 2024-12-18 | Magovcevic-liebisch Ivana (President and CEO) | Buy | 5,000 | 1.67 | 8,350 |
| 2024-12-05 | Magovcevic-liebisch Ivana (President and CEO) | Buy | 5,000 | 2.34 | 11,700 |
| 2023-11-20 | Magovcevic-liebisch Ivana (President and CEO) | Buy | 4,000 | 3.75 | 15,000 |
| 2022-11-18 | Papapetropoulos Spyros (Chief Medical Officer) | Sale | 300 | 14.00 | 4,200 |
| 2022-11-18 | Papapetropoulos Spyros (Chief Medical Officer) | Option Ex | 300 | 1.89 | 567 |
| 2022-05-17 | Thorp Clay (Director) | Buy | 14,893 | 2.97 | 44,187 |
| 2022-05-16 | Thorp Clay (Director) | Buy | 21,802 | 2.76 | 60,217 |
| 2022-05-05 | Thackaberry Evan (SVP, Head of Early Development) | Buy | 1,500 | 4.00 | 6,000 |
| 2022-05-03 | Verni Christopher (General Counsel) | Buy | 4,000 | 3.77 | 15,076 |
| 2022-05-03 | Papapetropoulos Spyros (Chief Medical Officer) | Buy | 4,000 | 3.40 | 13,592 |
| 2022-05-03 | Ziolkowski Jennifer Lynn (Chief Financial Officer) | Buy | 4,000 | 3.77 | 15,096 |
| 2022-05-03 | Magovcevic-liebisch Ivana (President and CEO) | Buy | 1,000 | 3.94 | 3,940 |
| 2022-05-02 | Magovcevic-liebisch Ivana (President and CEO) | Buy | 4,000 | 3.61 | 14,440 |
| 2022-03-28 | Thorp Clay (Director) | Buy | 3,000 | 7.20 | 21,603 |
| 2022-01-11 | Rubin Michael P. (10% Owner) | Buy | 355,000 | 14.00 | 4,970,000 |
| 2022-01-11 | Vida Ventures Iii-a, L.p. (10% Owner) | Buy | 1,675,000 | 14.00 | 23,450,000 |
| 2022-01-11 | Vitorovic Stefan (Director) | Buy | 1,675,000 | 14.00 | 23,450,000 |
| 2022-01-11 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Buy | 535,000 | 14.00 | 7,490,000 |
| 2022-01-11 | Thorp Clay (Director) | Buy | 265,000 | 14.00 | 3,710,000 |
| 2022-01-11 | Booth Bruce (Director) | Buy | 535,000 | 14.00 | 7,490,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of VIGL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vigil Neuroscience, Inc. (symbol VIGL, CIK number 1827087) see the Securities and Exchange Commission (SEC) website.